ConductScience.org, home

Gene · 2348

Trials46

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource
NCT03552471MIRVETUXIMAB SORAVTANSINEPHASE1ClinicalTrials.gov
NCT03106077MIRVETUXIMAB SORAVTANSINEPHASE22020-11-19ClinicalTrials.gov
NCT03045393MIRVETUXIMAB SORAVTANSINEPHASE1ClinicalTrials.gov
NCT02996825MIRVETUXIMAB SORAVTANSINEPHASE1ClinicalTrials.gov
NCT02631876MIRVETUXIMAB SORAVTANSINEPHASE32020-06-09ClinicalTrials.gov
NCT02606305MIRVETUXIMAB SORAVTANSINEPHASE1/PHASE22024-02-14ClinicalTrials.gov
NCT02289950FARLETUZUMABPHASE22021-09-02ClinicalTrials.gov
NCT02049281VINTAFOLIDEPHASE1ClinicalTrials.gov
NCT01953536VINTAFOLIDEPHASE2ClinicalTrials.gov
NCT01688791VINTAFOLIDEPHASE1ClinicalTrials.gov
NCT01609556MIRVETUXIMAB SORAVTANSINEPHASE12021-02-17ClinicalTrials.gov
NCT01577654VINTAFOLIDEPHASE2ClinicalTrials.gov
NCT01218516FARLETUZUMABPHASE22020-08-20ClinicalTrials.gov
NCT01203618FARLETUZUMABPHASE2ClinicalTrials.gov
NCT01170650VINTAFOLIDEPHASE3ClinicalTrials.gov
NCT01049061FARLETUZUMABPHASE1ClinicalTrials.gov
NCT01018563FARLETUZUMABPHASE22021-12-08ClinicalTrials.gov
NCT01004380FARLETUZUMABPHASE1ClinicalTrials.gov
NCT01002924VINTAFOLIDEPHASE2ClinicalTrials.gov
NCT00849667FARLETUZUMABPHASE32022-12-30ClinicalTrials.gov

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/2348/trials?page=2